Share on

Global Pediatric Healthcare Market Size, Share, Trends, COVID-19 Impact & Growth Analysis Report – Segmented By Type (Chronic Illness and Acute Illness), Treatment (Vaccines, Drugs and Others), Indication (Cardiac Disorders, Metabolic Disorders, Asthma and Allergies, Genetic Disorders and Other Indications), Distribution Channel & Region (North America, Europe, Asia-Pacific, Latin America, Middle East and Africa) – Industry Forecast from 2023 to 2028

Published: March, 2023
ID: 13493
Pages: 150
Formats: report pdf report excel report power bi report ppt

Global Pediatric Healthcare Market Size (2023 to 2028)

The global pediatric healthcare market size is anticipated to value USD 63.35 billion by 2028 from USD 45.13 billion in 2023, growing at a CAGR of 7.02% from 2023 to 2028.

MARKET DRIVERS:

The growing incidence of chronic diseases among children propels the pediatric healthcare market.

A spike has been noticed in the number of children suffering from various chronic diseases in the recent past. As a result, the awareness levels among parents have increased, primarily driving the market growth. Moreover, such serious diseases have led to the high adoption of the Pediatric Intensive Care Unit (PICU), which is present in almost every general hospital where the sickest pediatric patients are admitted. Also, the neonatal intensive care unit (NICU) is present in hospitals for preterm babies.

This specialized hospital unit provides the following:

  • Care For Respiratory Care
  • Level II Trauma
  • Medical And Surgical Intensive Care
  • Neurology
  • Open Heart Surgery

YOY rise in the number of pediatricians across the world is further anticipated to boost the market's growth rate.

There has been a rise in the number of pediatricians worldwide. Pediatricians are specialized professionals for preventing, detecting, and managing various problems affecting the miniature version of adult men and women, the children, who are under continuous growth and development, unlike adults. In addition, most general pediatricians worldwide collaborate with pediatric subspecialists to treat complex diseases and disorders in children and other healthcare professionals to meet the emotional needs of their patients, thereby providing effective treatment to the children. The general duties performed by a pediatric healthcare professional focus on reducing infant and child mortality through better and new treatments, identifying and addressing developmental and behavioral issues, diagnosis and treatment of infections, injuries, diseases, and dysfunctions, providing age-appropriate screenings and vaccinations, promote healthy lifestyles for children to minimize the prevalence of disease, monitoring physical and psychosocial growth and development of every individual child, provide counseling patients and parents on foreseeable developmental issues for better treatment options.

Furthermore, according to research, seeing the same pediatrician would help the child have better overall health since he knows the child and the family well, helping make the best recommendations. In addition, they give effective pediatric care through effective communication, essential services to children and parents, and the latest medical care to children up to 21 years of age, regarded as pediatric by the American Academy of Paediatrics (AAP).                          

A growing number of R&D activities are further expected to propel the global pediatric healthcare market.

The rise in the efforts of R&D to develop pediatric therapies, which could result in the release of new treatments, is anticipated to drive market expansion. The development of life-saving tools for kids due to the rising burden of illnesses, viral infections, and cases of malnutrition improved parental awareness of more diagnoses. Furthermore, various infectious disorders, such as diarrhea, pneumonia, malaria, and preterm birth and intrapartum complications cases yearly, have further led to market expansion. Moreover, these diseases have led to the introduction of rescue ambulances in most countries with specialized equipment for children, like a more powerful oxygen system, a baby carrier isolator, and a ventilator, since these diseases have been continuing to stand as the leading causes of death among children worldwide. Thus, driving the overall growth of the global pediatric healthcare market,

MARKET RESTRAINTS:

A significant challenge faced by the pediatric healthcare market is funding for Medicaid, estimated at 20% of total funding, which is used for nursing homes in a much smaller population. Also, children requiring hospitalization or specialist care result in a considerable increase in total cost compared to the low cost of ordinary pediatric care, further obstructing market growth. Moreover, the small size of the study population, high cost of research, ethical issues in pediatric research, complications associated with pediatric drugs related to the absorption of antidiarrheal drugs, and use of traditional home remedies which are still prevalent in developing countries are some of the other factors which are further anticipated to restraint the growth of the market.

Impact of COVID-19 on the global pediatric healthcare market:

Pediatricians are medical professionals specialized in the care of children, becoming the first stop for children's healthcare. Pediatric care includes various subspecialties in addition to providing general healthcare, such as developmental and behavioral problems, adolescent medicine, intensive care, and child abuse. Primary care providers or PCPs are general pediatricians, physician assistants, and pediatric nurse practitioners, which greatly help in most types of routine or non-emergency health care, supervising care during hospitalization of a child, helping in annual physical exams, helping patients control their weight, advice on check-ups and vaccinations. Moreover, a pediatrician is responsible for treating various child problems related to rheumatology, cardiology, palliative care and medicine, pulmonology, nephrology, neonatology, oncology, endocrinology, hematology, sports medicine, infectious diseases, transplant hepatology, and emergency medicine provision.

The COVID-19 pandemic had a positive impact on the global pediatric healthcare market. This is because the pandemic adversely affected children's mental health and well-being due to public health restrictions, leading to a more significant impact of disabilities and chronic health conditions in children. This led to greater demand for promising pediatric healthcare among the parent population for better treatment of their children, raising child protection concerns for vulnerable diseases. Consequently, there has been an increase in vaccination programs worldwide, which is further accelerated the growth of the global pediatric healthcare market.

REPORT COVERAGE:

REPORT METRIC

DETAILS

Market Size Available

2022 to 2028

Base Year

2022

Forecast Period

2023 to 2028

Segments Analysed

By type, treatment, indication, and region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges; PESTLE Analysis; Porter's Five Forces Analysis, Competitive Landscape, Analyst Overview of Investment Opportunities

Regions Analysed

North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa.

The global pediatric healthcare market research report has been segmented and sub-segmented based on the type, treatment, indication, and region.

Global Pediatric Healthcare Market - By Type:

  • Chronic Illness
  • Acute Illness

Based on type, the chronic illness segment is expected to hold a significant share in the global pediatric healthcare market during the forecast period owing to various disabilities faced by children because of chronic illnesses, such as frequent pain or discomfort, activity limitations, abnormal growth and development, and other severe disabilities, resulting in more outpatient visits, hospitalizations, and medical treatments. 

The acute illness segment is also anticipated to grow at a healthy CAGR during the forecast period owing to the facilities provided for pediatric acute care, such as injuries caused by falls and car accidents; serious infections such as pneumonia; traumatic brain injury; cuts and burns; and broken bones challenging to heal. These involve treating less severe injuries and illnesses, requiring adopting a hospital's children's intensive care unit.

Global Pediatric Healthcare Market - By Treatment:

  • Vaccines
  • Drugs
  • Others

Based on treatment, the pediatric vaccines segment is anticipated to lead the market during the forecast period. Pediatric vaccines help the well-being of children. Governments and doctors recommend they protect children against epidemics of various kinds of diseases. Moreover, the vaccines save families time and prevent them from entering financial burdens. 

On the other hand, the pediatric drugs segment is anticipated to hold a considerable share of the global market during the forecast period owing to the optimization and advancement of all aspects of drug therapy for healthcare professionals focusing on developing pediatric drug therapy.

Global Pediatric Healthcare Market - By Indication:

  • Cardiac Disorders
  • Metabolic Disorders
  • Asthma and Allergies
  • Genetic Disorders
  • Other Indications

Based on the indication, the genetic disorders segment is anticipated to dominate over the forecast period owing to the growing number of such diseases among the pediatric population worldwide. These include developmental problems, certain types of congenital disabilities, chronic conditions, and sensory impairments inherited by the child from one or both parents, requiring various tests to detect genetic disorders and promote the segment's growth. 

The cardiac disorders segment is anticipated to account for a considerable share of the global market during the forecast period due to the increasing prevalence of various heart disorders in the pediatric population. According to the CDC, in every 1,000 live births, 8 to 10 children are seen with a congenital heart defect, becoming the most common congenital disability worldwide. The congenital heart diseases affecting children may be narrowed valves, hypoplastic chambers, leaking valves, holes in the heart walls, or even in severe cases, a combination of many defects is seen, which require either extensive surgery or correctable with a single procedure. Therefore, this is anticipated to drive market growth in this segment.

Global Pediatric Healthcare Market - By Region:

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

North America dominated the pediatric healthcare market in 2021 and is anticipated to account for a leading global market share throughout the forecast period. The surge in the adoption of advanced technologies in countries such as the United States, the high burden of pediatric disease in the North American region, increasing drug approvals in the United States, and the rising number of pediatric patient cases with children who have cerebral palsy, autism, muscle atrophy, and respiratory disorders are majorly driving the pediatric healthcare market in North America. Moreover, more than 40% of school-aged children and adolescents in the U.S. have at least one chronic health condition, which resulted in the launch of new products by key players for pediatric patients to treat their chronic diseases. In addition, the focus of the key market participants in North America has recently increased to offer cost-effective services in terms of patient care, along with the development and adoption of pediatric therapies in this country, which is further anticipated to boost the market's growth rate.

The European pediatric healthcare market is expected to hold a substantial share of the global market in 2022. Factors such as an increase in government initiatives to raise awareness of pediatric treatments and disorders among the parent population, various service providers offering a wide range of services to meet the growing need and high demand for effective and better treatment procedures by both parents and pediatricians and improved healthcare infrastructure across Europe are boosting the market growth.

The APAC pediatric healthcare market is anticipated to showcase the highest CAGR in the global market during the forecast period. YOY growth in the number of children with diseases in the countries of the Asia-Pacific region, increase in government initiatives, and other educational institutions to raise awareness of pediatric treatments and disorders are favoring the market growth in this region. In addition, increasing R&D investments, growing awareness among parents regarding the availability of advanced treatments, and new product launches by key players to bring improvements in healthcare infrastructure medical for pediatric patients, leading to high adoption of telehealth services, especially in countries such as Japan, China, and India are supporting the market growth in this region.

KEY MARKET PLAYERS:

Gilead Sciences, GlaxoSmithKline Plc., Eli Lilly, Sanofi, Abbott, Bristol-Myers Squibb Company, AxcanPharma USA, Johnson and Johnson, Pfizer, and Wyeth are a few of the notable companies in the pediatric healthcare market.

RECENT MARKET DEVELOPMENTS:

  • In November 2022, the technology company known for developing the award-winning Miku Pro, Miku Care, introduced an in-app software plug-in, Care+, for tracking changes in their child's unique sleeping and breathing patterns and personal wellness tracking adults. It also can adjust parents' daily habits and nighttime routines, which are key indicators of general well-being.
  • In November 2022, Canada will be importing one million bottles of children's pain and fever medicine, as said by federal officials, to help ease a months-long shortage due to rising positive tests for RSV and influenza, which have a significant impact on children.

Please wait. . . . Your request is being processed

FAQ's

Which Region holds the largest revenue share during the forecast period.

The North American pediatric healthcare market is expected to grow significantly and hold the largest revenue share during the forecast period.

what is the compound annual growth rate (CAGR%) of the pediatric healthcare market during the forecast period?

The global pediatric healthcare market is expected to grow at a CAGR of 7.02% during the forecast period.

who are the key players of the global pediatric healthcare market?

Gilead Sciences, GlaxoSmithKline Plc., Eli Lilly, Sanofi, Abbott, Bristol-Myers Squibb Company, AxcanPharma USA, Johnson and Johnson, and Pfizer are some of the key market players global pediatric healthcare market.

Related Reports

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2500

Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM

Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!

REACH OUT TO US

Call us on: +1 888 702 9696 (U.S Toll Free)

Write to us: [email protected]

Click for Request Sample